The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort study

The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort study

Abstract Aim To evaluate the safety and efficacy of FreeFlow percutaneous atrial septal shunt device (manufactured by AOLIU Medical Technology Co., Ltd, Shanghai, China) in patients with refractory pulmonary arterial hypertension (PAH) for the first time. Methods The study enrolled adult patients di...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingfei Li, Dandan Chen, Jianing Fan, Dan Tian, Lei Zhang, Xiaochun Zhang, Shasha Chen, Yuan Zhang, Wenzhi Pan, Lihua Guan, Daxin Zhou, Junbo Ge
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Respiratory Research
Subjects:
Percutaneous atrial septal shunt
Refractory pulmonary arterial hypertension
Quality of life
Heart failure
Online Access:https://doi.org/10.1186/s12931-025-03159-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12931-025-03159-z

Similar Items